Stonepine Capital Management LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | UroGen Pharma Ltd. URGN | Stonepine Capital Management LLC | 0 0.000% | -1,304,947 (Position Closed) | Filing |
| 2023-02-13 10:57 am Purchase | 2022-12-31 | 13G | UroGen Pharma Ltd. URGN | Stonepine Capital Management LLC | 1,304,947 5.700% | 108,039 (+9.03%) | Filing |
| 2022-12-02 11:15 am Purchase | 2022-11-22 | 13G | UroGen Pharma Ltd. URGN | Stonepine Capital Management LLC | 1,196,908 5.200% | 1,196,908 (New Position) | Filing |